Correlation Between ZyVersa Therapeutics and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Revelation Biosciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Revelation Biosciences.
Diversification Opportunities for ZyVersa Therapeutics and Revelation Biosciences
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ZyVersa and Revelation is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Revelation Biosciences go up and down completely randomly.
Pair Corralation between ZyVersa Therapeutics and Revelation Biosciences
Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Revelation Biosciences. In addition to that, ZyVersa Therapeutics is 1.49 times more volatile than Revelation Biosciences. It trades about -0.16 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about 0.02 per unit of volatility. If you would invest 1.29 in Revelation Biosciences on August 27, 2024 and sell it today you would lose (0.06) from holding Revelation Biosciences or give up 4.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ZyVersa Therapeutics vs. Revelation Biosciences
Performance |
| Timeline |
| ZyVersa Therapeutics |
| Revelation Biosciences |
ZyVersa Therapeutics and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ZyVersa Therapeutics and Revelation Biosciences
The main advantage of trading using opposite ZyVersa Therapeutics and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
| Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. HCW Biologics | Revelation Biosciences vs. Scpharmaceuticals | Revelation Biosciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |